0-52315
(Commission
File Number)
|
2301
Dupont Drive, Suite 525
Irvine,
CA 92612
|
20-1915083
(IRS
Employer Identification No.)
|
|
|
·
|
effected
a 1-for-200 reverse stock split of the Registrant’s outstanding common
stock, with special treatment for certain of the Registrant’s stockholders
to preserve round lot holders;
|
|
·
|
decreased
the number of authorized shares of common stock from 2,000,000,000 to
100,000,000; and
|
|
·
|
authorized
10,000,000 shares of “blank check” preferred
stock.
|
|
·
|
stockholders
holding less than 100 shares of the Registrant’s common stock were not
affected,
|
|
·
|
stockholders
holding 20,000 or fewer shares of the Registrant’s common stock, but at
least 100 shares of the Registrant’s common stock, were provided special
treatment such that after the reverse stock split, those holders continue
to hold 100 shares of the Registrant’s common stock;
and
|
|
·
|
no
fractional shares resulted as all fractional shares were rounded up to the
next whole number of shares.
|
|
(d)
|
Exhibits.
|
Exhibit
Number
|
Description of Exhibit
|
|
3.1
|
Amended
and Restated Certificate of
Incorporation.
|
AtheroNova
Inc.
|
|||
Date: June
25, 2010
|
By:
|
/s/ Mark Selawski | |
Mark Selawski | |||
Chief
Financial Officer & Secretary
|
|||